PTC Therapeutics, Inc. (PTCT)
71.06
+1.24
(+1.78%)
USD |
NASDAQ |
Aug 24, 16:00
71.02
-0.04
(-0.06%)
After-Hours: 20:00
PTC Therapeutics Total Liabilities (Quarterly) : 3.416B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.416B |
| March 31, 2026 | 3.050B |
| December 31, 2025 | 3.117B |
| September 30, 2025 | 2.799B |
| June 30, 2025 | 2.841B |
| March 31, 2025 | 2.841B |
| December 31, 2024 | 2.815B |
| September 30, 2024 | 2.897B |
| June 30, 2024 | 2.897B |
| March 31, 2024 | 2.684B |
| December 31, 2023 | 2.722B |
| September 30, 2023 | 1.931B |
| June 30, 2023 | 1.917B |
| March 31, 2023 | 2.066B |
| December 31, 2022 | 2.053B |
| September 30, 2022 | 1.803B |
| June 30, 2022 | 1.986B |
| March 31, 2022 | 1.890B |
| December 31, 2021 | 1.937B |
| September 30, 2021 | 1.902B |
| June 30, 2021 | 1.862B |
| March 31, 2021 | 1.819B |
| December 31, 2020 | 1.726B |
| September 30, 2020 | 1.670B |
| June 30, 2020 | 904.14M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.017B |
| December 31, 2019 | 1.029B |
| September 30, 2019 | 977.83M |
| June 30, 2019 | 802.89M |
| March 31, 2019 | 770.97M |
| December 31, 2018 | 768.50M |
| September 30, 2018 | 642.54M |
| June 30, 2018 | 244.37M |
| March 31, 2018 | 229.10M |
| December 31, 2017 | 235.22M |
| September 30, 2017 | 221.84M |
| June 30, 2017 | 213.35M |
| March 31, 2017 | 147.82M |
| December 31, 2016 | 149.76M |
| September 30, 2016 | 148.00M |
| June 30, 2016 | 139.94M |
| March 31, 2016 | 139.23M |
| December 31, 2015 | 142.04M |
| September 30, 2015 | 126.95M |
| June 30, 2015 | 25.24M |
| March 31, 2015 | 26.20M |
| December 31, 2014 | 34.75M |
| September 30, 2014 | 19.50M |
| June 30, 2014 | 13.80M |
| March 31, 2014 | 11.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.345B |
| Madrigal Pharmaceuticals, Inc. | 720.92M |
| Protagonist Therapeutics, Inc. | 44.00M |
| Biogen, Inc. | 13.24B |
| BioMarin Pharmaceutical, Inc. | 5.402B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.250B |
| Shareholders Equity (Quarterly) | -165.36M |
| Debt to Equity Ratio | -4.212 |
| Current Ratio | 3.394 |
| Net Debt Paydown Yield | -0.90% |